Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group
Revvity (NYSE: RVTY) has secured a favorable ruling from the Massachusetts Superior Court, which will issue a permanent injunction enforcing its agreements with Cloud Software Group (CSG) regarding Spotfire® software. This follows a preliminary injunction from April 2024 and ensures continued access to Spotfire software and support for Revvity and its customers through 2034.
The ruling maintains Revvity's position as the exclusive provider of Spotfire in research and clinical markets, safeguarding operational continuity and service quality for customers. The company expressed satisfaction with the court's decision to uphold the agreements and emphasized its commitment to maintaining service reliability.
Revvity (NYSE: RVTY) ha ottenuto un'ordinanza favorevole dal Tribunale Superiore del Massachusetts, che emetterà un'ingiunzione permanente a tutela dei suoi accordi con Cloud Software Group (CSG) riguardanti il software Spotfire®. Questo segue un'ingiunzione preliminare di aprile 2024 e garantisce l'accesso continuo al software Spotfire e al supporto per Revvity e i suoi clienti fino al 2034.
La sentenza mantiene la posizione di Revvity come fornitore esclusivo di Spotfire nei mercati della ricerca e clinici, salvaguardando la continuità operativa e la qualità del servizio per i clienti. L'azienda ha espresso soddisfazione per la decisione del tribunale di confermare gli accordi, sottolineando il suo impegno a mantenere l'affidabilità del servizio.
Revvity (NYSE: RVTY) ha conseguido un fallo favorable del Tribunal Superior de Massachusetts, que emitirá una orden de restricción permanente que hará cumplir sus acuerdos con Cloud Software Group (CSG) en relación con el software Spotfire®. Esto sigue a una orden de restricción preliminar de abril de 2024 y asegura el acceso continuo al software Spotfire y al soporte para Revvity y sus clientes hasta 2034.
El fallo mantiene la posición de Revvity como proveedor exclusivo de Spotfire en los mercados de investigación y clínicos, protegiendo la continuidad operativa y la calidad del servicio para los clientes. La empresa expresó su satisfacción con la decisión del tribunal de mantener los acuerdos y enfatizó su compromiso con la fiabilidad del servicio.
Revvity (NYSE: RVTY)는 매사추세츠 고등법원에서 유리한 판결을 받아 Cloud Software Group (CSG)와의 Spotfire® 소프트웨어 관련 계약을 집행하는 영구 금지 명령을 발부받게 되었습니다. 이는 2024년 4월에 발부된 임시 금지 명령에 이어지는 것으로, Revvity와 그 고객이 2034년까지 Spotfire 소프트웨어 및 지원에 지속적으로 접근할 수 있도록 보장합니다.
이 판결은 연구 및 임상 시장에서 Spotfire의 독점 공급자로서 Revvity의 입장을 유지하며, 고객을 위한 운영 연속성과 서비스 품질을 보호합니다. 회사는 법원의 계약 유지 결정에 대한 만족감을 표현하며 서비스 신뢰성 유지를 위한 헌신을 강조했습니다.
Revvity (NYSE: RVTY) a obtenu un jugement favorable du Tribunal Supérieur du Massachusetts, qui émettra une injonction permanente pour faire respecter ses accords avec Cloud Software Group (CSG) concernant le logiciel Spotfire®. Cela fait suite à une injonction préliminaire d'avril 2024 et garantit un accès continu au logiciel Spotfire et au support pour Revvity et ses clients jusqu'en 2034.
Le jugement maintient la position de Revvity en tant que fournisseur exclusif de Spotfire sur les marchés de la recherche et clinique, protégeant la continuité opérationnelle et la qualité du service pour les clients. L'entreprise a exprimé sa satisfaction quant à la décision du tribunal de maintenir les accords et a souligné son engagement à garantir la fiabilité du service.
Revvity (NYSE: RVTY) hat eine günstige Entscheidung des Obersten Gerichts von Massachusetts erlangt, das eine permanente einstweilige Verfügung erlassen wird, um seine Vereinbarungen mit der Cloud Software Group (CSG) bezüglich der Spotfire®-Software durchzusetzen. Dies folgt auf eine einstweilige Verfügung aus April 2024 und sichert den fortlaufenden Zugang zur Spotfire-Software und Unterstützung für Revvity und seine Kunden bis 2034.
Das Urteil sichert Revvitys Position als exklusiver Anbieter von Spotfire in den Forschungs- und Klinikmärkten und schützt die betriebliche Kontinuität sowie die Servicequalität für die Kunden. Das Unternehmen äußerte Zufriedenheit mit der Entscheidung des Gerichts, die Vereinbarungen zu bestätigen, und betonte sein Engagement für die Aufrechterhaltung der Servicezuverlässigkeit.
- Secured permanent injunction protecting rights to Spotfire software
- Guaranteed exclusive provider status in research and clinical markets through 2034
- Ensures uninterrupted access and support for customers
- None.
Insights
The Massachusetts Superior Court's ruling represents a strategic victory that extends far beyond mere legal compliance. The permanent injunction securing Revvity's exclusive rights to Spotfire software through 2034 effectively eliminates a significant operational risk that could have disrupted the company's core business operations and customer relationships.
The ruling's implications are particularly significant for three key reasons:
- It safeguards Revvity's position as the exclusive provider of Spotfire in research and clinical markets, maintaining a important competitive advantage in the life sciences technology sector.
- The long-term nature of the agreement (through 2034) provides exceptional business stability and enables confident long-term strategic planning and investment in platform development.
- The preservation of uninterrupted access ensures continuity for Revvity's customers, protecting both current revenue streams and future growth opportunities in the research and clinical markets.
From a strategic perspective, this ruling effectively transforms what could have been a significant business risk into a sustained competitive moat. The guaranteed access to Spotfire technology through 2034 allows Revvity to focus on innovation and market expansion rather than potential service disruptions or legal challenges.
The court's decision also strengthens Revvity's negotiating position for future technology partnerships and validates their business model of providing integrated software solutions to the life sciences sector. This stability is particularly valuable in the current market environment, where reliable access to critical research tools and software platforms is essential for pharmaceutical and biotechnology companies.
This ruling follows a preliminary injunction issued in April 2024, which will become permanent, ensuring uninterrupted access to Spotfire software and support for Revvity and its customers, protecting operational continuity and service quality.
“We are pleased with the court's decision upholding our agreements and the commitments made to our customers,” said Kevin Willoe, SVP and general manager at Revvity Signals Software. “This ruling reinforces our dedication to delivering the reliable, high-quality service that empowers scientists to drive meaningful discoveries. We look forward to continuing our historically collaborative and productive partnership with CSG as the exclusive provider of Spotfire to the research and clinical markets through 2034 and hopefully beyond.”
About Revvity
At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.
With 2024 revenue of more than
Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250220424412/en/
Investor Relations:
Steve Willoughby
steve.willoughby@revvity.com
Media Relations:
Chet Murray
(781) 462-5126
chet.murray@revvity.com
Source: Revvity
FAQ
What did the Massachusetts Court rule in favor of Revvity (RVTY) regarding Spotfire software?
How long will Revvity (RVTY) maintain exclusive rights to Spotfire in research and clinical markets?
What was the outcome of Revvity's (RVTY) legal dispute with Cloud Software Group?
How does the court ruling affect Revvity's (RVTY) customers using Spotfire software?
